1. Home
  2. OBAI vs LEXX Comparison

OBAI vs LEXX Comparison

Compare OBAI & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TG-17 Inc. Common Stock

OBAI

TG-17 Inc. Common Stock

N/A

Current Price

$0.34

Market Cap

9.4M

ML Signal

N/A

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

HOLD

Current Price

$9.37

Market Cap

8.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OBAI
LEXX
Founded
2017
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.4M
8.7M
IPO Year
2025
2011

Fundamental Metrics

Financial Performance
Metric
OBAI
LEXX
Price
$0.34
$9.37
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.50
AVG Volume (30 Days)
2.4M
73.0K
Earning Date
05-27-2026
04-13-2026
Dividend Yield
N/A
N/A
EPS Growth
40.53
N/A
EPS
N/A
N/A
Revenue
$9,972,000.00
$705,923.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$601.47
P/E Ratio
N/A
N/A
Revenue Growth
2.42
52.05
52 Week Low
$0.31
$0.35
52 Week High
$19.95
$14.37

Technical Indicators

Market Signals
Indicator
OBAI
LEXX
Relative Strength Index (RSI) 37.32 51.19
Support Level $0.31 $0.62
Resistance Level $0.48 $12.89
Average True Range (ATR) 0.04 1.46
MACD 0.01 -0.27
Stochastic Oscillator 17.39 12.05

Price Performance

Historical Comparison
OBAI
LEXX

About OBAI TG-17 Inc. Common Stock

Our Bond Inc is a personal security service through its AI-powered Preventive Personal Security platform. It is trusted by corporations, cities, and universities, and has already supported many security service requests, emergencies and life-saving interventions. The cloud-based Bond Preventative Personal Security Platform provides users with remote protective services via phone app (using its Bond Preventative Personal Security Platform) and with 24/7 support from its Personal Security Agents, who are in Bond Command Centers and can respond rapidly. It offers distinct services through its phone app (the Bond App) and fully automated Bond Command Centers. Geographically, the company operates in Israel, France, and United States. It derives maximum revenue from United States.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

Share on Social Networks: